PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-24.91%
Negative net income growth while AVGO stands at 18.46%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-9.09%
Negative yoy D&A while AVGO is 0.14%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
1350.00%
Well above AVGO's 3.83% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-14.58%
Both cut yoy SBC, with AVGO at -13.92%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
62.22%
Well above AVGO's 3.75% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
248.05%
AR growth is negative or stable vs. AVGO's 575.00%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
No Data
No Data available this quarter, please select a different quarter.
-200.00%
Both negative yoy AP, with AVGO at -160.25%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
8.75%
Some yoy usage while AVGO is negative at -77.35%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-195.65%
Both negative yoy, with AVGO at -5.88%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-11.95%
Negative yoy CFO while AVGO is 2.48%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-9.40%
Negative yoy CapEx while AVGO is 14.29%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
9.40%
Less M&A spending yoy vs. AVGO's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-109.94%
Negative yoy purchasing while AVGO stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
38.64%
We have some liquidation growth while AVGO is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-5.41%
Both yoy lines negative, with AVGO at -90.70%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-110.18%
Both yoy lines negative, with AVGO at -151.43%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-75.26%
Negative yoy issuance while AVGO is 436.36%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-7.24%
We cut yoy buybacks while AVGO is 39.92%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.